Search
for
Sort by
Research 181–210 of 220
- Case of alemtuzumab-related alopecia areata management in MS
- Advances in clinical applications of microneedle
- Evaluating the Metabolomic Profile and Anti-Pathogenic Properties of Cannabis Species
- Shortcutting the diagnostic odyssey: the multidisciplinary Program for Undiagnosed Rare Diseases in adults (UD-PrOZA)
- Advances in 3D printing for the repair of tympanic membrane perforation: a comprehensive review
- Head and Neck 3D Bioprinting—A Review on Recent Advancements in Soft Tissue 3D Bioprinting and Medical Applications
- How Biotin Induces Misleading Results in Thyroid Bioassays: Case Series
- SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms
- The association of medications and supplements with human male reproductive health: a systematic review
- Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology
- Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets
- Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients
- Persistent scurvy after vitamin C supplementation in a high-risk patient: a case report
- Uveodermatological syndrome associated with alopecia areata in a one‐year‐old female spayed Cavalier King Charles Spaniel dog
- Newly emerging type B insulin resistance (TBIR) during treatment with eculizumab for AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD): fatal outcome
- Long-acting microneedle formulations
- Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
- Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis?
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- A Comprehensive Review of Acne Treatments: Unpacking the Chemical Structures and Effective Bioactive Compounds
- Hair Cortisol as a Biomarker of Chronic Stress in Community-Dwelling Adults With Longstanding Multiple Sclerosis
- Ophthalmologic Comorbidities in Alopecia Areata
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Review of Promising Off-Label Use of Deucravacitinib
- A Fuzzy Logic-Based Computational Framework for Precision Triage in Androgenetic Alopecia: A Simulated Biomarker-Driven Approach
- New insights into the phenomenon of remissions and relapses in autoimmune diseases and the puzzle of benign autoantibodies in healthy individuals
- The Impact of Diet and Lifestyle on the Course of Autoimmune Diseases
- How Biodegradable Polymers Can be Effective Drug Delivery Systems for Cannabinoids? Prospectives and Challenges